{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:57:05Z","timestamp":1791619025150,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","biologicalpsychiatryjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopsych.2024.05.020","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T01:45:14Z","timestamp":1717379114000},"page":"752-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Presynaptic and Postsynaptic Mesolimbic Dopamine D3 Receptors Play Distinct Roles in Cocaine Versus Opioid Reward in Mice"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-8104","authenticated-orcid":false,"given":"Zheng-Xiong","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam E.","family":"Bocarsly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Galaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Teresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlisa","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Linz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Alton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Freyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-4072","authenticated-orcid":false,"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2024.05.020_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.biopsych.2024.05.020_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1176\/appi.ajp.2018.17101174","article-title":"Neuroscience of addiction: Relevance to prevention and treatment","volume":"175","author":"Volkow","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2024.05.020_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuron.2019.01.016","article-title":"The molecular basis of drug addiction: Linking epigenetic to synaptic and circuit mechanisms","volume":"102","author":"Nestler","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2024.05.020_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: From structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biopsych.2024.05.020_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2024.05.020_bib6","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1021\/acs.jmedchem.5b01612","article-title":"Novel analogues of (R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) provide clues to dopamine D2\/D3 receptor agonist selectivity","volume":"59","author":"Zou","year":"2016","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2024.05.020_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","article-title":"Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA","volume":"564","author":"Bouthenet","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2024.05.020_bib8","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1523\/JNEUROSCI.20-23-08677.2000","article-title":"Dopamine D3 receptors expressed by all mesencephalic dopamine neurons","volume":"20","author":"Diaz","year":"2000","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainresrev.2004.12.033","article-title":"The role of central dopamine D3 receptors in drug addiction: A review of pharmacological evidence","volume":"49","author":"Heidbreder","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.biopsych.2024.05.020_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: Comparison with D2 receptor expressing neurons","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2024.05.020_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib12","first-page":"1232","article-title":"Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments","volume":"295","author":"Stanwood","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2024.05.020_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/7854_2022_347","article-title":"Current perspectives on selective dopamine D3 receptor antagonists\/partial agonists as pharmacotherapeutics for opioid and psychostimulant use disorders","volume":"60","author":"Newman","year":"2023","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173072","article-title":"Progress in opioid reward research: From a canonical two-neuron hypothesis to two neural circuits","volume":"200","author":"Galaj","year":"2021","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2024.05.020_bib15","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1523\/JNEUROSCI.4371-11.2012","article-title":"Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: A positron emission tomography study","volume":"32","author":"Boileau","year":"2012","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/syn.10170","article-title":"Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats","volume":"47","author":"Le","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2024.05.020_bib17","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1523\/JNEUROSCI.16-19-06100.1996","article-title":"Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities","volume":"16","author":"Staley","year":"1996","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/npp.2013.192","article-title":"Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: A positron emission tomography study with [11C]-+-PHNO","volume":"39","author":"Payer","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2024.05.020_bib19","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.neuron.2021.05.002","article-title":"Ventral pallidum DRD3 potentiates a pallido-habenular circuit driving accumbal dopamine release and cocaine seeking","volume":"109","author":"Pribiag","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2024.05.020_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1749-6632.1999.tb09286.x","article-title":"D3 dopamine and kappa Opioid receptor alterations in human brain of cocaine-overdose victims","volume":"877","author":"Mash","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.npp.1300456","article-title":"Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: Implications for cocaine-seeking behavior","volume":"29","author":"Neisewander","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2024.05.020_bib22","doi-asserted-by":"crossref","first-page":"17675","DOI":"10.1073\/pnas.1205297109","article-title":"Increased vulnerability to cocaine in mice lacking dopamine D3 receptors","volume":"109","author":"Song","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biopsych.2024.05.020_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2018.08.016","article-title":"Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice","volume":"141","author":"Zhan","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2024.05.020_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2010.09.025","article-title":"Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration","volume":"485","author":"Li","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2024.05.020_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41401-018-0153-0","article-title":"Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice","volume":"40","author":"Lv","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.biopsych.2024.05.020_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1523\/JNEUROSCI.23-03-01006.2003","article-title":"Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion","volume":"23","author":"Narita","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainres.2011.11.045","article-title":"Role of dopamine D3 receptors in basal nociception regulation and in morphine-induced tolerance and withdrawal","volume":"1433","author":"Li","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2024.05.020_bib28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41386-019-0371-2","article-title":"Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens","volume":"44","author":"Manvich","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2024.05.020_bib29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrn3104","article-title":"Opiate versus psychostimulant addiction: The differences do matter","volume":"12","author":"Badiani","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrn3939","article-title":"The dopamine theory of addiction: 40 years of highs and lows","volume":"16","author":"Nutt","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00210-008-0384-6","article-title":"Should we be cautious on the use of commercially available antibodies to dopamine receptors?","volume":"379","author":"Bodei","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.biopsych.2024.05.020_bib32","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1523\/JNEUROSCI.0310-17.2017","article-title":"D3 receptors regulate excitability in a unique class of prefrontal pyramidal cells","volume":"37","author":"Clarkson","year":"2017","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nn.2862","article-title":"Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors","volume":"14","author":"Bello","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107583","article-title":"Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder","volume":"213","author":"Chen","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2024.05.020_bib35","first-page":"475","article-title":"Dopamine D2 and D3 receptors inhibit dopamine release","volume":"270","author":"Tang","year":"1994","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2024.05.020_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050479","article-title":"The D3 dopamine receptor in cellular and organismal function","volume":"135","author":"Shafer","year":"1998","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.biopsych.2024.05.020_bib37","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1523\/JNEUROSCI.0479-19.2019","article-title":"Striatal cholinergic interneurons are a novel target of corticotropin releasing factor","volume":"39","author":"Lemos","year":"2019","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib38","first-page":"145","article-title":"Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: Evidence for a potential novel binding site","volume":"278","author":"Levant","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2024.05.020_bib39","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/acs.jmedchem.6b00860","article-title":"Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the D3R crystal structure: New leads for opioid dependence treatment","volume":"59","author":"Kumar","year":"2016","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2024.05.020_bib40","doi-asserted-by":"crossref","first-page":"9061","DOI":"10.1021\/acs.jmedchem.9b00607","article-title":"Investigation of novel primary and secondary pharmacophores and 3-substitution in the linking chain of a series of highly selective and bitopic dopamine D3 receptor antagonists and partial agonists","volume":"62","author":"Shaik","year":"2019","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2024.05.020_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pbb.2003.11.002","article-title":"Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2\/3 receptor agonists in mice","volume":"77","author":"Cook","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2024.05.020_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00008877-199304000-00006","article-title":"Pharmacological characterization of the discriminative stimulus properties of the dopamine D1 agonist, SKF 81297","volume":"4","author":"Reavill","year":"1993","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2024.05.020_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207694","article-title":"Optogenetic self-stimulation in the nucleus accumbens: D1 reward versus D2 ambivalence","volume":"13","author":"Cole","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2024.05.020_bib44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nn.3100","article-title":"Distinct roles for direct and indirect pathway striatal neurons in reinforcement","volume":"15","author":"Kravitz","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neuron.2017.12.022","article-title":"Nucleus accumbens subnuclei regulate motivated behavior via direct inhibition and disinhibition of VTA dopamine subpopulations","volume":"97","author":"Yang","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2024.05.020_bib46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00726-017-2408-3","article-title":"Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice","volume":"49","author":"Stojanovic","year":"2017","journal-title":"Amino Acids"},{"key":"10.1016\/j.biopsych.2024.05.020_bib47","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/npp.2010.133","article-title":"Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications","volume":"35","author":"Peng","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2024.05.020_bib48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-0173(83)90038-3","article-title":"The role of dopamine in locomotor activity and learning","volume":"287","author":"Beninger","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2024.05.020_bib49","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1126\/science.1237059","article-title":"Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area","volume":"341","author":"Bocklisch","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2024.05.020_bib50","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1523\/JNEUROSCI.1504-11.2011","article-title":"Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area","volume":"31","author":"Xia","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.05.020_bib51","article-title":"Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors","author":"Enriquez-Traba","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopsych.2024.05.020_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neubiorev.2020.04.024","article-title":"Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges","volume":"114","author":"Galaj","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2024.05.020_bib53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/npp.2016.155","article-title":"CTDP-32476: A promising agonist therapy for treatment of cocaine addiction","volume":"42","author":"Xi","year":"2017","journal-title":"Neuropsychopharmacology"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322324013581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322324013581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T15:22:40Z","timestamp":1728487360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322324013581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0006322324013581"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2024.05.020","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presynaptic and Postsynaptic Mesolimbic Dopamine D3 Receptors Play Distinct Roles in Cocaine Versus Opioid Reward in Mice","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2024.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc on behalf of Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}